{
    "clinical_study": {
        "@rank": "93919", 
        "arm_group": {
            "arm_group_label": "Study Group", 
            "description": "Participants must have received Menactra Vaccine according to routine clinical practice."
        }, 
        "brief_summary": {
            "textblock": "This is a passive-surveillance study that will accrue subjects for surveillance. For each\n      accrued subject, surveillance for outcomes will continue for six months following the first\n      dose. If a second dose is given within that time, then surveillance will be continued for\n      six months following the second dose.\n\n      Observational Objective:\n\n        -  To describe and characterize adverse events occurring after vaccination with Menactra\n           vaccine."
        }, 
        "brief_title": "Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Meningitis", 
            "Meningococcal Infection"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Meningitis", 
                "Meningococcal Infections"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study will be carried out in collaboration with the Kaiser Permanente Medical Care\n      Program (KPMCP) under the direction of the Kaiser Permanente Vaccine Study Center (KPVSC).\n      KPMCP is a closed-panel healthcare organization that maintains comprehensive encounter\n      databases that capture all medical care received by enrollees.\n\n      Vaccination will be according to routine clinical practice. Vaccination databases will be\n      reviewed to identify eligible persons receiving Menactra vaccine within the KPMCP system."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 9 to 23 months at the time of receipt of the first dose of Menactra vaccine\n             during the study period."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "23 Months", 
            "minimum_age": "9 Months", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Participants at age 9 to 23 months at the time of receipt of the first dose of Menactra\n        vaccine according to routine clinical practice during the study period."
            }
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01689155", 
            "org_study_id": "MTA57", 
            "secondary_id": "U 1111-1120-1574"
        }, 
        "intervention": {
            "arm_group_label": "Study Group", 
            "description": "0.5 mL, Intramuscular", 
            "intervention_name": "Menactra\u00ae: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate", 
            "intervention_type": "Biological", 
            "other_name": "Menactra\u00ae"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Meningitis", 
            "Meningococcal Infection", 
            "Menactra\u00ae"
        ], 
        "lastchanged_date": "April 1, 2014", 
        "link": [
            {
                "url": "http://www.sanofipasteur.com"
            }, 
            {
                "url": "http://www.sanofiaventis.com"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Oakland", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94612"
                }
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Post-licensure Safety Surveillance Study of Menactra\u00ae Vaccine When Administered As a 2-dose Schedule to Children 9 Months Through 23 Months of Age.", 
        "overall_official": {
            "affiliation": "Sanofi Pasteur Inc.", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Surveillance will include all emergency room visits, hospitalizations and related databases will be reviewed to identify all medical care events for vaccinees.", 
            "measure": "Number of adverse events (AEs) and serious adverse events (SAEs) reported in the database following Menactra vaccination.", 
            "safety_issue": "No", 
            "time_frame": "Up to 6 months post-vaccination"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01689155"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Sanofi", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sanofi Pasteur, a Sanofi Company", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}